Related Experiment Videos
[Differentiated surgical therapy of diffuse peritonitis--a prospective study]
G J Winkeltau1, P Bertram, J Braun
1Chirurgische Klinik der RWTH Aachen.
Leber, Magen, Darm
|May 1, 1996
Summary
This study on diffuse peritonitis found that tailored treatments based on the Mannheim Peritonitis-Score (MPS) significantly impacted patient outcomes, with lower mortality in milder stages and higher in severe stages.
Area of Science:
- Surgical Gastroenterology
- Clinical Medicine
- Infectious Diseases
Context:
- Diffuse peritonitis presents a significant clinical challenge with varying severity.
- The Mannheim Peritonitis-Score (MPS) is a tool for stratifying peritonitis severity.
- Treatment protocols for peritonitis often require adaptation based on disease stage.
Purpose:
- To evaluate the efficacy of different treatment strategies for diffuse peritonitis based on the Mannheim Peritonitis-Score (MPS).
- To assess the correlation between peritonitis severity, treatment approach, and patient mortality.
- To compare observed mortality rates with statistically predicted values using MPS and APACHE-II scores.
Summary:
- A prospective study included 86 patients with diffuse peritonitis, categorized into three stages using the MPS (Stage I: 0-20, Stage II: 21-29, Stage III: >29).
- Treatment varied by stage: standard procedure for Stage I, closed postoperative lavage for Stage II, and "Etappenlavage" (reexplorations and lavage) for Stage III.
- Mortality rates were 3% for Stage I, 24% for Stage II, and 33% for Stage III, with an overall mortality of 17%.
Impact:
- The findings demonstrate that tailored treatment strategies guided by the MPS can influence patient outcomes in diffuse peritonitis.
- The study highlights the prognostic value of the MPS in predicting mortality risk.
- Observed mortality was lower than predicted by MPS and APACHE-II scores, suggesting potential benefits of the applied treatment protocols.